Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

Much to the consternation of parents, teachers and cruise ship enthusiasts, there are no approved treatments ... furthest along is Moderna, which has developed a norovirus vaccine with the same ...

including an extensive pipeline of therapeutics in clinical trials that could be the booster shot the stock needs to generate a rebound. Let's discuss the pros and cons of buying Moderna stock.

As Moderna (NASDAQ: MRNA ... The products with the biggest earning potential that could be approved are its combination shot for influenza and COVID, its influenza vaccine, and its next-generation ...

Germany's health ministry has said it will start offering booster COVID-19 vaccines ... The European Medicines Agency has approved the Pfizer/BioNTech and Moderna shots for all over-12s.

Moderna Receives $590M From HHS to Develop Bird Flu Vaccine By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS ...

Moderna launched its RSV vaccine last year, following earlier approved vaccines from Pfizer (PFE) and GSK (GSK). A health worker prepares a Moderna COVID-19 vaccine at a vaccination center.

while adoption of its RSV shot - its second approved product- has been slower than expected, forcing Moderna to cut costs. The company expects $1.5 billion to $2.5 billion in annual revenue ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...